ライフサイエンスコーパス: rest pain

1 tment of critical limb ischaemia with severe rest pain.

2 ischemic ulceration or gangrene rather than rest pain.

3 s are more likely to present with ulcers and rest pain.

4 d transcutaneous oxygen tension, and reduced rest pain.

5 n; P =.05 for 25-mg rofecoxib vs celecoxib), rest pain (-21.8, - 18.6, - 15.5, and - 12.5 mm; P</=.02

6 e, 68.9+/-11.9 years; 40.8% women; 24.6% for rest pain, 37.2% for ulcer, and 38.2% for gangrene).

7 s with claudication (3 vs 5 days, P = 0.01), rest pain (5 vs 6 days, P = 0.02), and tissue loss (6 vs

8 f thoracic epidural analgesia vs opioids for rest pain after thoracic surgery (weighted mean differen

9 ERP patients with rest pain also had a shorter total LOS (6 vs 7 days, P =

10 Relief of rest pain and healing of ulcerations and amputations wer

11 til symptoms like intermittent claudication, rest pain and ischemic gangrene develop, are not present

12 Recent rest pain and refractory or postinfarction UA, or both,

13 rked by intractable lower extremity ischemic rest pain and tissue loss, is a highly morbid condition

14 Critical limb ischemia is characterized by rest pain and/or tissue loss and has a > or = 40% risk o

15 d with claudication, 3% were associated with rest pain, and 1% were associated with ischemic tissue l

16 heals amputations and ulcerations, relieves rest pain, and improves ambulation.

17 ts most severe form, critical limb ischemia, rest pain, and tissue necrosis are associated with high

18 achial index, transcutaneous oxygen tension, rest pain, and walking capacity after cell therapy.

19 Secondary outcomes quality of life, rest pain, ankle-brachial index, and transcutaneous oxyg

20 The Numerical Rating Scale scores of resting pain at each time point after the blockage were

21 s with intermittent claudication or ischemic rest pain attributable to superficial femoral and poplit

22 th intermittent claudication and/or ischemic rest pain caused by femoropopliteal lesions; 1397 patien

23 Bowel rest, pain control, and intravenous fluids are the corne

24 sciatic nerve block for the relief of severe rest pain during endovascular treatment of critical limb

25 k as an alternative method to relieve severe rest pain during endovascular treatment of critical limb

26 ational Classification of Diseases codes for rest pain, foot ulcers, and gangrene.

27 d the terms critical limb ischemia, ischemic rest pain, gangrene, or extremity ulcers.

28 nkle brachial index by > or =0.10, relief of resting pain, healing of ulceration or amputation, and i

29 grene or ulceration in 42 patients (81%) and rest pain in 10 patients (19%).

30 nt placement were claudication in 312 (62%), rest pain in 107 (21%), ulcer in 67 (13%), and gangrene

31 (46.3%) or limb-threatening ischemia (52.7%; rest pain in 27.7% and tissue loss in 72.3%).

32 gangrene or ischemic ulceration rather than rest pain increased with declining renal function (70, 7

33 eterans who received an initial diagnosis of rest pain, ischemic ulceration, or gangrene between Janu

34 ss all CLTI-related diagnoses (patients with rest pain: low Medicaid burden, 29.8%; high Medicaid bur

35 Unstable angina patients with rest pain (n = 28) had greater mean plaque Lp(a) area th

36 h nonhealing ischemic ulcers (n=7/10) and/or rest pain (n=10/10) due to peripheral arterial disease.

37 , diagnosis codes for claudication (N=8128), rest pain (N=3056), and ulceration/gangrene (N=11,770) a

38 eg pain, and, in more severe cases, ischemic rest pain, neuropathic pain, or phantom limb pain in tho

39 nts (<55 y) revealed higher rates of pain at rest, pain on exertion, and pain requiring treatment (ea

40 A clinical success (relief of rest pain or improvement of lower-extremity blood flow)

41 al vein bypass for the treatment of ischemic rest pain or ischemic tissue loss.

42 Randomized patients with rest pain or ischemic ulcers and TcPo(2) <40 mm Hg and/o

43 articipants with critical limb ischemia with rest pain or tissue loss with atherosclerotic disease in

44 ing ischaemia (CLTI) is defined as ischaemic rest pain, or non-healing ulceration, requiring endovasc

45 claudication (P=0.003), a similar trend for rest pain (P=0.061), and no improvement for ulceration/g

46 s were present in 543 patients (43.8%), with rest pain present in 645 (52.1%).

47 on of 4.79 to 8.62 points) and postoperative rest pain (reduction of 1.18 to 2.03 points).

48 ons in HIF-1alpha patients included complete rest pain resolution in 14 of 32 patients and complete u

49 Patients with claudication or ischemic rest pain (Rutherford class 2-4) and superficial femoral

50 ssue loss was present in 40 (91%) limbs, and rest pain was present in four (9%); technical success oc

51 ne hundred two patients with claudication or rest pain were randomly assigned 1:1 to DA+DCB (n=48) or

52 osite of survival with remission of ischemic rest pain, wound healing, and freedom from major lower-e